Victory Capital Management Inc Supernus Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 742,871 shares of SUPN stock, worth $28.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
742,871
Previous 735,038 1.07%
Holding current value
$28.1 Million
Previous $19.7 Million 17.8%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$25.77 - $35.16 $201,856 - $275,408
7,833 Added 1.07%
742,871 $23.2 Million
Q2 2024

Aug 05, 2024
BUY
$25.99 - $33.85 $2.27 Million - $2.95 Million
87,200 Added 13.46%
735,038 $19.7 Million
Q1 2024

May 03, 2024
SELL
$27.11 - $35.17 $1.15 Million - $1.5 Million
-42,560 Reduced 6.16%
647,838 $22.1 Million
Q4 2023

Feb 05, 2024
SELL
$22.72 - $29.68 $471,917 - $616,483
-20,771 Reduced 2.92%
690,398 $20 Million
Q3 2023

Nov 06, 2023
BUY
$27.57 - $32.91 $1.45 Million - $1.73 Million
52,468 Added 7.97%
711,169 $19.6 Million
Q2 2023

Jul 27, 2023
SELL
$29.91 - $38.73 $60,866 - $78,815
-2,035 Reduced 0.31%
658,701 $19.8 Million
Q1 2023

May 02, 2023
SELL
$34.93 - $42.03 $876,812 - $1.06 Million
-25,102 Reduced 3.66%
660,736 $23.9 Million
Q4 2022

Feb 10, 2023
BUY
$31.09 - $37.88 $159,149 - $193,907
5,119 Added 0.75%
685,838 $24.5 Million
Q4 2022

Feb 09, 2023
SELL
$31.09 - $37.88 $3.01 Million - $3.66 Million
-96,750 Reduced 12.44%
680,719 $24.3 Million
Q3 2022

Nov 02, 2022
SELL
$28.79 - $35.41 $208,756 - $256,757
-7,251 Reduced 0.92%
777,469 $26.3 Million
Q2 2022

Aug 01, 2022
SELL
$25.33 - $34.25 $1.39 Million - $1.88 Million
-54,882 Reduced 6.54%
784,720 $22.7 Million
Q1 2022

May 04, 2022
SELL
$28.51 - $32.9 $217,844 - $251,388
-7,641 Reduced 0.9%
839,602 $26.9 Million
Q4 2021

Feb 07, 2022
SELL
$26.37 - $34.22 $514,399 - $667,529
-19,507 Reduced 2.25%
847,243 $24.7 Million
Q3 2021

Nov 02, 2021
BUY
$23.54 - $31.39 $5.36 Million - $7.15 Million
227,872 Added 35.67%
866,750 $23.1 Million
Q2 2021

Aug 03, 2021
BUY
$26.72 - $33.19 $5.82 Million - $7.23 Million
217,931 Added 51.77%
638,878 $19.7 Million
Q1 2021

May 04, 2021
SELL
$24.15 - $31.45 $169,219 - $220,370
-7,007 Reduced 1.64%
420,947 $11 Million
Q4 2020

Feb 01, 2021
SELL
$17.7 - $25.81 $1.04 Million - $1.52 Million
-58,891 Reduced 12.1%
427,954 $10.8 Million
Q3 2020

Nov 09, 2020
BUY
$20.2 - $25.05 $9.28 Million - $11.5 Million
459,351 Added 1670.73%
486,845 $10.1 Million
Q2 2020

Aug 07, 2020
BUY
$17.09 - $24.89 $32,710 - $47,639
1,914 Added 7.48%
27,494 $653,000
Q1 2020

May 04, 2020
SELL
$14.45 - $24.69 $41,731 - $71,304
-2,888 Reduced 10.14%
25,580 $460,000
Q4 2019

Feb 06, 2020
BUY
$19.93 - $29.13 $19,830 - $28,984
995 Added 3.62%
28,468 $675,000
Q4 2019

Feb 04, 2020
BUY
$19.93 - $29.13 $116,590 - $170,410
5,850 Added 27.05%
27,473 $628,000
Q3 2019

Nov 12, 2019
BUY
$25.47 - $33.37 $499,313 - $654,185
19,604 Added 970.98%
21,623 $594,000
Q2 2019

Aug 15, 2019
SELL
$29.96 - $38.87 $105,069 - $136,317
-3,507 Reduced 63.46%
2,019 $67,000
Q1 2019

May 03, 2019
SELL
$32.77 - $41.99 $65,867 - $84,399
-2,010 Reduced 26.67%
5,526 $194,000
Q4 2018

Feb 05, 2019
BUY
$30.84 - $49.51 $9,128 - $14,654
296 Added 4.09%
7,536 $250,000
Q3 2018

Nov 01, 2018
BUY
$42.7 - $56.55 $131,516 - $174,174
3,080 Added 74.04%
7,240 $365,000
Q2 2018

Aug 02, 2018
BUY
$44.1 - $59.85 $25,137 - $34,114
570 Added 15.88%
4,160 $249,000
Q1 2018

May 04, 2018
BUY
$37.15 - $46.9 $31,428 - $39,677
846 Added 30.83%
3,590 $164,000
Q4 2017

Feb 01, 2018
BUY
$36.4 - $42.6 $8,699 - $10,181
239 Added 9.54%
2,744 $109,000
Q3 2017

Oct 27, 2017
SELL
$36.75 - $49.65 $34,398 - $46,472
-936 Reduced 27.2%
2,505 $100,000
Q2 2017

Aug 07, 2017
BUY
N/A
3,441
3,441 $148,000

Others Institutions Holding SUPN

# of Institutions
283
Shares Held
60.8M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.03B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email